20:40 , Apr 26, 2019 |  BC Week In Review  |  Company News

FDA panel to review candidate for hard-to-treat tuberculosis

FDA’s Antimicrobial Drugs Advisory Committee will meet June 6 to discuss an NDA from Global Alliance for TB Drug Development (TB Alliance) for oral pretomanid (PA-824) to treat adults with pulmonary extensively drug resistant and...
18:10 , Aug 31, 2018 |  BC Week In Review  |  Clinical News

TB Alliance starts pivotal trial of four-drug regimen

The Global Alliance for TB Drug Development (TB Alliance) began the pivotal Phase IIc SimpliciTB trial evaluating an oral four-drug regimen called BPaMZ to treat tuberculosis. SimpliciTB will compare BPaMZ, which comprises a once-daily combination...
20:43 , Aug 28, 2018 |  BC Extra  |  Clinical News

TB Alliance starts pivotal trial of four-drug regimen

The Global Alliance for TB Drug Development (TB Alliance) began the pivotal Phase IIc SimpliciTB trial evaluating an oral four-drug regimen called BPaMZ to treat tuberculosis. SimpliciTB will compare BPaMZ, which comprises a once-daily combination...
21:43 , Oct 27, 2017 |  BC Week In Review  |  Company News

Astellas partners with TB Alliance to develop new TB drugs

Astellas Pharma Inc. (Tokyo:4503) partnered with non-profit organization Global Alliance for TB Drug Development to identify new drugs to treat tuberculosis (TB). Astellas will provide its original compound library, which TB Alliance will screen for...
00:06 , Aug 5, 2017 |  BioCentury  |  Regulation

Enabling efficiency in TB

In combination with adaptive study designs, a real-time biomarker of treatment response that is making its way toward FDA could shave years off the development of tuberculosis regimens, according to multiple stakeholders who attended a...
21:45 , Dec 7, 2016 |  BC Innovations  |  Strategy

The Sharing Economy

Arguably the biggest indicator that pharmas have shed the isolationist, know-it-all attitudes that drove their strategies for decades is the growth of compound-sharing initiatives to spur drug discovery. A handful of companies is leading the...
07:00 , Oct 3, 2016 |  BC Week In Review  |  Company News

Kenya Ministry of Health, TB Alliance sales and marketing update

The Kenya Ministry of Health, TB Alliance and other partners launched in Kenya the first child-friendly formulation of tuberculosis drugs. TB Alliance said the pills are flavored and dissolve in water. Kenya Ministry of Health...
07:00 , Jun 27, 2016 |  BC Week In Review  |  Company News

Takeda, TB Alliance deal

TB Alliance and Takeda partnered to develop compounds to treat tuberculosis. The compounds were generated from a high throughput screening program using Takeda’s library of 20,000 compounds under a 2013 deal between TB Alliance and...
01:17 , Apr 21, 2016 |  BC Extra  |  Politics & Policy

TB Alliance partners with Medicines Patent Pool

The Global Alliance for TB Drug Development and the Medicines Patent Pool (MPP) will collaborate to share IP and form licensing strategies for future tuberculosis treatments developed by the TB Alliance. The partners aim to...
07:00 , Oct 19, 2015 |  BioCentury  |  Regulation

Unleashing China's innovators

An ambitious slate of reforms proposed by China's State Council could at last relieve the regulatory bottlenecks that have long hobbled development of innovative drugs in and for China by domestic and multinational pharmas alike....